General synthesis and biological evaluation of α-1-C-substituted derivatives of fagomine (2-deoxynojirimycin-α-C-glycosides)

Bioorganic and Medicinal Chemistry

Volumn 13, Issue 6, 2005, Pages 2313-2324

  Goujon, Jean Yves ^a   Gueyrard, David ^a   Compain, Philippe ^a   Martin, Olivier R ^a   Ikeda, Kyoko ^b   Kato, Atsushi ^c   Asano, Naoki ^b  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b HOKURIKU UNIVERSITY   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRADEOXY 2,6 IMINO 1 MORPHOLINO DEXTRO MANNOHEPTITOL; 2,3,6 TRIDEOXY 2,6 IMINO DEXTRO MANNOHEPTITOL; 2,3,6 TRIDEOXY 2,6 IMINO DEXTRO MANNOHEPTITOL 1 PHOSPHATE; ALCOHOL; AMINE; AZIRIDINE; CARBOXYLIC ACID; FAGOMINE; GLUCONATE CALCIUM; GLYCOGEN PHOSPHORYLASE B; GLYCOSIDASE INHIBITOR; PHOSPHATE; PHOSPHOGLUCOMUTASE; THIOL; TRI O BENZYL DEXTRO GLUCAL; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; INHIBITION KINETICS; REACTION ANALYSIS; RING OPENING;

EID: 13844312017     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2004.12.043     Document Type: Article

References (71)

1. H. Paulsen Angew. Chem., Int. Ed. Engl. 78 1966 495
2. S. Inouye, T. Tsuruoka, and T. Niida J. Antibiot., Ser. A 19 1966 288
3. A.E. Stütz Iminosugars as Glycosidase Inhibitors Nojirimycin and Beyond 1999 Wiley-VCH New York For a historical background, see Chapter 1 by Paulsen, H. 'The Early Days of Monosaccharides Containing Nitrogen in the Ring'
4. N. Asano, R.J. Nash, R.J. Molyneux, and G.W.J. Fleet Tetrahedron: Asymmetry 11 2000 1645
5. P. Compain, and O.R. Martin Curr. Top. Med. Chem. 3 2003 541
6. P. Compain, and O.R. Martin Bioorg. Med. Chem. 9 2001 3077
7. P. Sears, and C.-H. Wong Angew. Chem., Int. Ed. 38 1999 2300
8. H. Moriyama, T. Tsukida, Y. Inoue, H. Kondo, K. Yoshino, and S.-I. Nishimura Bioorg. Med. Chem. Lett. 13 2003 2737
9. H. Moriyama, T. Tsukida, Y. Inoue, K. Yokota, K. Yoshino, H. Kondo, N. Miura, and S.-I. Nishimura J. Med. Chem. 47 2004 1930
10. P. Jakobsen, J.M. Lundbeck, M. Kristiansen, J. Breinholt, H. Demuth, J. Pawlas, M.P. Torres Candela, B. Andersen, N. Westergaard, K. Lundgren, and N. Asano Bioorg. Med. Chem. 9 2001 733
11. R.E. Lee, M.D. Smith, L. Pickering, and G.W.J. Fleet Tetrahedron Lett. 39 1999 8689
12. R.E. Lee, M.D. Smith, R.J. Nash, R.C. Griffiths, M. McNeil, R.K. Grewal, W. Yan, G.S. Besra, P.J. Brennan, and G.W.J. Fleet Tetrahedron Lett. 38 1997 6733
13. V.L. Schramm, and P.C. Tyler Curr. Top. Med. Chem. 3 2003 525
14. G.B. Evans, R.H. Furneaux, A. Lewandowicz, V.L. Schramm, and P.C. Tyler J. Med. Chem. 46 2003 5271
15. A. Fedorov, W. Shi, G. Kicska, E. Fedorov, P.C. Tyler, R.H. Furneaux, J.C. Hanson, G.J. Gainsford, J.Z. Larese, V.L. Schramm, and S.C. Almo Biochemistry 40 2001 853
16. R.W. Miles, P.C. Tyler, R.H. Furneaux, C. Bagdassarian, and V.L. Schramm Biochemistry 37 1998 8615
17. P.C. Kline, and V.L. Schramm Biochemistry 32 1993 13212
18. Iminosugars: Recent Insights Into Their Bioactivity and Potential As Therapeutic Agents in Curr. Top. Med. Chem.; Martin, O. R.; Compain, P. Eds.; Bentham, Neth., 2003, 3, issue 5
19. J. Alper Science 291 2001 2338
20. A. Mitrakou, N. Tountas, A.E. Raptis, R.J. Bauer, H. Schulz, and S.A. Raptis Diabetes Med. 15 1998 657
21. T.D. Butters, R.A. Dwek, and F.M. Platt Curr. Top. Med. Chem. 3 2003 561
22. T.D. Butters, A. Dwek, and F.M. Platt Chem. Rev. 100 2000 4683
23. T. Cox, R. Lachmann, C. Hollak, J. Aerts, S. van Weely, M. Hrebicek, F. Platt, T. Butters, R. Dwek, C. Moyses, I. Gow, D. Elstein, and A. Zimran The Lancet 355 2000 1481
24. A.C. Van der Spoel, M. Jeyakumar, T.D. Butters, H.M. Charlton, H.D. Moore, R.A. Dwek, and F.M. Platt Proc. Natl. Acad. Sci. U.S.A. 99 2002 17173
25. For selected recent references see: G. Godin, E. Garnier, P. Compain, O.R. Martin, K. Ikeda, and N. Asano Tetrahedron Lett. 45 2004 579
26. G. Godin, P. Compain, and O.R. Martin Org. Lett. 5 2003 3269
27. G. Godin, P. Compain, G. Masson, and O.R. Martin J. Org. Chem. 67 2002 6960
28. H. Nojima, I. Kimura, C. Fu-Jin, Y. Sugihara, M. Haruno, A. Kato, and N. Asano J. Nat. Prod. 61 1998 397
29. S. Taniguchi, N. Asano, F. Tomino, and I. Miwa Horm. Metab. Res. 30 1998 679
30. N. Asano, M. Nishida, M. Miyauchi, K. Ikeda, M. Yamamoto, H. Kizu, Y. Kameda, A.A. Watson, R.J. Nash, and G.W.J. Fleet Phytochemistry 53 2000 379
31. For synthesis of a close analog of 4, (+)-5-deoxyadenophorine [(2R,3S,4S,6R)-2-hydroxymethyl-6-ethylpiperidine], see: F.-X. Felpin, K. Boubekeur, and J. Lebreton J. Org. Chem. 69 2004 1497
32. 20
33. M.K. Tong, and B. Ganem J. Am. Chem. Soc. 110 1988 312
34. H. Paulsen, M. Matzke, B. Orthen, R. Nuck, and W. Reutter Liebigs Ann. Chem. 10 1990 953
35. B. Bernet, A.R.C. Bulusu Murty, and A. Vasella Helv. Chim. Acta 73 1990 940
36. O.R. Martin, F. Xie, and L. Liu Tetrahedron Lett. 36 1995 4027
37. O.R. Martin, and O. Saavedra Tetrahedron Lett. 36 1995 799
38. J.-Y. Goujon, D. Gueyrard, P. Compain, O.R. Martin, and N. Asano Tetrahedron: Asymmetry 14 2003 1969
39. For ring-opening reactions of a bicyclic aziridine having the 1-azabicyclo[4.1.0]heptan-2-one skeleton see: X. Wu, S. Toppet, F. Compernolle, and G.J. Hoornaet Tetrahedron 59 2003 1483
40. V. Costantino, C. Imperatore, E. Fattorusso, and A. Mangoni Tetrahedron Lett. 41 2000 9177
41. J. Désiré, P.J. Dransfield, P.M. Gore, and M. Shipman Synlett 2001 1329
42. M.A. Tius, and J. Busch-Petersen Tetrahedron Lett. 35 1994 5181
43. O.R. Martin, L. Liu, and F. Yang Tetrahedron Lett. 37 1996 1991
44. A. Boschetti, F. Nicotra, L. Panza, and G. Russo J. Org. Chem. 53 1988 4181
45. For recent reviews see: X.E. Hu Tetrahedron 60 2004 2701
46. J.B. Sweeney Chem. Soc. Rev. 31 2002 247
47. W. McCoull, and F.A. Davis Synthesis 10 2000 1347
48. For selected references see: J.F. Hayes, M. Shipman, and H. Twin J. Org. Chem. 67 2002 935
49. J. Eis, and B. Ganem Tetrahedron Lett. 26 1985 1153
50. G. Sekar, and V.K. Singh J. Org. Chem. 64 1999 2537
51. A. Caiazzo, S. Dalili, and A.K. Yudin Org. Lett. 4 2002 2597
52. J. Mulzer, R. Becker, and E. Brunner J. Am. Chem. Soc. 111 1989 7500
53. J.M. Concellon, E. Riego, and J.R. Suarez J. Org. Chem. 68 2003 9242
54. J.S. Yadav, B.V. Subba Reddy, G. Parimala, and P. Venkatram Reddy Synthesis 16 2002 2383
55. For an example of opening of an N-activated aziridine by a phosphate see: K. Misiura, R.W. Kinas, W.J. Stec, H. Kusnierczyk, C. Radzikowski, and A. Sonoda J. Med. Chem. 31 1988 226
56. C.W. Jefford, and J. Wang Tetrahedron Lett. 34 1993 1111
57. Unpublished results
58. A. Kato, N. Asano, H. Kizu, and K. Matsui J. Nat. Prod. 60 1997 312
59. N. Asano, K. Oseki, H. Kizu, and K. Matsui J. Med. Chem. 37 1994 3701
60. N. Asano, H. Kizu, K. Oseki, E. Tomioka, K. Matsui, M. Okamoto, and M. Baba J. Med. Chem. 38 1995 2349
61. N. Asano, M. Nishida, A. Kato, H. Kizu, K. Matsui, Y. Shimada, T. Itoh, M. Baba, A.A. Watson, R.J. Nash, P.M. de Q. Lilley, D.J. Watkin, and G.W.J. Fleet J. Med. Chem. 41 1998 2565
62. N. Asano, K. Oseki, E. Kaneko, and K. Matsui Carbohydr. Res. 258 1994 255
63. S.V. Evans, L.E. Fellows, T.K.M. Shing, and G.W.J. Fleet Phytochemistry 24 1985 1953
64. G. Legler Adv. Carbohydr. Chem. Biochem. 48 1990 319 384
65. It is well-known that the 2-OH group plays an important role in the transition-state stabilization of glycosidase-mediated glycoside hydrolyses
66. L. Somsak, V. Nagy, Z. Hadady, T. Docsa, and P. Gergely Curr. Pharm. Des. 9 2003 1177
67. J.L. Treadway, P. Mendys, and D. Hoover J. Exp. Opin. Invest. Drugs 10 2001 439
68. A.S. Ross, E.A. Gulve, and M. Wang Chem. Rev. 104 2004 1255 1282
69. MeOH or TSP are used as internal reference
70. M. Kessler, O. Acuto, C. Strelli, H. Murer, and G.A. Semenza Biochem. Biophys. Acta 506 1978 136
71. V.T. Maddaiah, and N.B. Madsen J. Biol. Chem. 241 1966 3873